Totus Medicines
Menu
Close
Platform
Pipeline
About us
Join us
News & Media
Home
Contact Us
Open Roles
LinkedIn
Twitter
News
News
&
Media
Articles
Press Releases
Updates
Search
Articles
View all Articles
ARTICLES
08.10.2023
Revolutionizing Drug Discovery with AI, Chemistry, and Biology
Learn more
ARTICLES
08.01.2023
Revolutionizing Pharma: A Deep Dive into WuXi AppTec's BOLD Series with Totus Medicines
Learn more
ARTICLES
07.17.2023
AI in Drug Discovery: Challenges and Opportunities
Learn more
ARTICLES
04.18.2023
New PI3Kα Inhibitor TOS-358 Begins Clinical Trials for Solid Tumors
Learn more
ARTICLES
03.02.2022
Small-Molecule Drugs: The Future of Medicine Beyond Complex Therapies
Learn more
ARTICLES
12.09.2021
Developing Treatments for ‘Undruggable’ Diseases - Totus Featured in Forbes
Learn more
ARTICLES
12.09.2021
Emerging from Stealth to Develop New PI3Kα Inhibitors for Cancer Treatment
Learn more
ARTICLES
New Cancer Drug TOS-358 Enters Phase I Trial with Accelerated Approval in Sight
Learn more
Press Releases
View all Press Releases
PRESS RELEASES
10.19.2023
John Maraganore, Ph.D. Joins Totus Medicines' Scientific Advisory Board
Learn more
PRESS RELEASES
09.27.2023
Totus Makes a Mark at Future of R&D Week in Boston
Learn more
PRESS RELEASES
04.13.2023
Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors
Learn more
PRESS RELEASES
04.12.2023
Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero
Learn more
PRESS RELEASES
04.10.2023
Totus Medicines Announces Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
Learn more
PRESS RELEASES
01.04.2023
BioSpace Names Most Promising New Biopharma Companies to Watch in 2023 PR Newswire 01 04 2023
Learn more
PRESS RELEASES
10.11.2022
Totus Medicines CEO to Present at Next-Generation Undruggable Conference
Learn more
PRESS RELEASES
05.05.2022
Totus Medicines Announces Global Pharma Leader Tom Hughes as Board Chair & Creation of Scientific Advisory Board
Learn more
PRESS RELEASES
03.31.2022
Totus Medicines Announces New San Francisco Bay Area Headquarters & Expanded Lab Space
Learn more
PRESS RELEASES
03.24.2022
Totus Medicines Partners with Mila to Advance Drug Discovery Technologies in Mission to Treat the Untreatable
Learn more
PRESS RELEASES
02.23.2022
Expert Clinical Developer Dr. Ovid Trifan and Veteran Drug Hunter Dr. Wei Chen Bring Decades of Complex Drug Development Experience to Totus Medicines
Learn more
PRESS RELEASES
01.11.2022
Totus Medicines to Present at 2022 J.P. Morgan HealthCare Conference
Learn more
PRESS RELEASES
01.06.2022
Totus Medicines Appoints Chief People Officer Daisy Chhokar and Chief Financial Officer Sam Singer to Senior Leadership Team
Learn more
PRESS RELEASES
12.09.2021
Totus Medicines Emerges from Stealth with Revolutionary Drug Program Targeting PI3K-Alpha Oncogene
Learn more
PRESS RELEASES
12.09.2021
Totus Medicines Emerges from Stealth with Revolutionary Drug Program Targeting PI3K-Alpha Oncogene
Learn more
Updates
View all Updates
UPDATES
10.04.2023
The Forefront of Innovative Drug Discovery and Development
Watch video
UPDATES
08.14.2023
Totus Medicines Wins Stevie Award in the 2023 International Business Awards
Learn more
UPDATES
01.04.2023
BioSpace Names Most Promising New Biopharma Companies to Watch in 2023
Learn more
A breakthrough cancer drug already, and more on the way.
About us